Mercy Arch Hematology Oncology is categorized under Hematologists in Saint Louis, MO and active since 2006.
Mercy Arch Hematology Oncology was established in 2006, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Hematologists business, which does work in the B2C market, and is classified as a Hematologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Burton M Needles at the company’s single location by writing to 607 South New Ballas Road # 3300, Saint Louis, Missouri MO 63141 or by phoning (314) 251-4260. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Mercy Arch Hematology Oncology |
| Contact Person: | Burton M Needles |
| Address: | 607 South New Ballas Road # 3300, Saint Louis, Missouri 63141 |
| Phone Number: | (314) 251-4260 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hematologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Mercy Arch Hematology Oncology was started in 2006 to provide professional Hematologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Burton M Needles for inquiries that concern Mercy Arch Hematology Oncology by calling the company number (314) 251-4260, as your correspondence is most welcome. Additionally, the physical location of the single location of Mercy Arch Hematology Oncology can be found at the coordinates 38.647482,-90.443555 as well as the street address 607 South New Ballas Road # 3300 in Saint Louis, Missouri 63141.
For its online presence, you may visit Mercy Arch Hematology Oncology’s website at and engage with its social media outlets through on Twitter and on Facebook.